[La...] Posted July 22, 2022 Share Posted July 22, 2022 The full title of this Italian study is "Phenobarbital use in benzodiazepine and z-drug detoxification: a single-centre 15-year observational retrospective study in clinical practice". https://pubmed.ncbi.nlm.nih.gov/35412225/ Abstract Given the increase in benzodiazepine (BZD) and Z-drug (ZD) use disorder, this study described the use of phenobarbital (PHB) as detoxification in clinical practice. A 15-year observational retrospective study was performed on medical records of BZD-ZD use disorder patients detoxified with PHB at the Toxicology Unit and Poison Centre, Careggi University Hospital, Florence (Italy). A multivariate logistic regression was used to estimate odd ratios (ORs) and related 95% confidence intervals (CI) of "treatment failure" considering demographic and pharmacological characteristics. "Hospitalisation length", "PHB discharge dose", and "BZD-ZD free status" at discharge were also calculated. During detoxification, out of 355 patients (57% of men), with a mean age of 42.92 years, only 20 (5.6%) treatment failures were recorded: 19 were discharged against medical advice or due to misbehaviour, and only one for PHB-related non-serious skin rash. Analysis showed a higher probability to be BZD-ZD free at discharge for subjects who reported to be employed (OR 2.29; CI 95% 1.00-5.24), for those who abused oral drops of BZD-ZD (OR 2.16, CI 1.30-3.59), and for those treated with trazodone (OR 2.86, CI 1.14-7.17) during hospital stay. A hospitalisation length of > 7 days was observed for patients with opioid maintenance therapy (OR 2.07, CI 1.20-3.58) for substance use disorder, and for those treated with more than 300 mg/day of PHB equivalents at hospital admission (OR 1.68, CI 1.03-2.72). Our results suggested that PHB can be considered a valuable detoxification option for different types of BZD and ZD use disorder patients. Link to comment Share on other sites More sharing options...
[Li...] Posted July 22, 2022 Share Posted July 22, 2022 Thank you for finding and sharing this, Lapis2. I’ve included a link to the full text below. As the authors note, a major limitation of this study is that it did not include a post-detox followup component. Phenobarbital use in benzodiazepine and z-drug detoxification: a single-centre 15-year observational retrospective study in clinical practice https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001824/ Link to comment Share on other sites More sharing options...
[Ju...] Posted July 26, 2022 Share Posted July 26, 2022 I was prescribed Primidone (another version and synthesis of Phenobarb) during the first half of my Klonopin withdrawal. I'm pretty sure that whenever I quit taking it, it threw me back into acute withdrawal. Although I'm not sure if it was the primidone, as I quit taking propranolol at the same time about a year or two ago. Link to comment Share on other sites More sharing options...
[La...] Posted July 26, 2022 Author Share Posted July 26, 2022 It's one thing to get a medication out of the body, but it's quite another to recover from long-term use of benzodiazepines. I think most of us have found out the hard way that it can take awhile. Unfortunately, I haven't come across many studies where people are actually followed over a long period of time, and I assume it's very hard to do such a study. Link to comment Share on other sites More sharing options...
[Na...] Posted July 26, 2022 Share Posted July 26, 2022 It's interesting to me that a study is actually using the phrase "benzodiazepine (BZD) and Z-drug (ZD) use disorder". That's a phrase more medical professionals need to become acquainted with. Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now